Antonio Giordano to Paclitaxel
This is a "connection" page, showing publications Antonio Giordano has written about Paclitaxel.
Connection Strength
0.073
-
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis. Lancet Oncol. 2019 10; 20(10):1360-1369.
Score: 0.040
-
Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation. Oncotarget. 2017 Apr 25; 8(17):28939-28958.
Score: 0.034